TACSTD2 and malignant colon neoplasm: In the Department of Surgery of Hebei Medical University in China, immunofluorescence analysis of TROP-2 was performed in paraffin-embedded colon cancer tissue specimens of 82 patients who had undergone surgery for colon cancer and had been treatment-naïve pre-operatively [19].